Équilibre Biopharmaceuticals
Amy Melsaether, MD is currently serving as the Chief Medical Officer at Graviton Bioscience. Prior to this role, Amy worked at Équilibre Biopharmaceuticals as the Senior Vice President Consultant for Clinical Research. With a strong background in radiology, Amy also held positions at Icahn School of Medicine at Mount Sinai and NYU Langone Medical Center. Amy's educational background includes a Doctor of Medicine degree from David Geffen School of Medicine at UCLA and a BS with honors in Biochemistry, Molecular Biology, and English from the University of Wisconsin-Madison.
Équilibre Biopharmaceuticals
Équilibre Biopharmaceuticals Corp. was established as an innovative biopharmaceutical company focused on identifying and developing high-potential drugs for patients who are treatment-resistant or unresponsive to other existing medications.